Cargando…
Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling
BACKGROUND: A cholesterol-palmitoyl interaction has been reported to occur in the dimeric interface of the β(2)-adrenergic receptor crystal structure. We sought to investigate whether a similar phenomenon could be observed with μ-opioid receptor (OPRM1), and if so, to assess the role of cholesterol...
Autores principales: | Zheng, Hui, Pearsall, Elizabeth A, Hurst, Dow P, Zhang, Yuhan, Chu, Ji, Zhou, Yali, Reggio, Patricia H, Loh, Horace H, Law, Ping-Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317874/ https://www.ncbi.nlm.nih.gov/pubmed/22429589 http://dx.doi.org/10.1186/1471-2121-13-6 |
Ejemplares similares
-
Molecular mechanism of CD44 homodimerization modulated by palmitoylation and membrane environments
por: Ma, Ziyi, et al.
Publicado: (2022) -
Effect of Opioid on Adult Hippocampal Neurogenesis
por: Zhang, Yue, et al.
Publicado: (2016) -
Regulation of G protein-coupled receptors by palmitoylation and cholesterol
por: Goddard, Alan D, et al.
Publicado: (2012) -
Src‐dependent phosphorylation of μ‐opioid receptor at Tyr(336) modulates opiate withdrawal
por: Zhang, Lei, et al.
Publicado: (2017) -
Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels
por: Huang, Zhenhua, et al.
Publicado: (2016)